105 related articles for article (PubMed ID: 15611503)
1. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.
Chi SN; Gardner SL; Levy AS; Knopp EA; Miller DC; Wisoff JH; Weiner HL; Finlay JL
J Clin Oncol; 2004 Dec; 22(24):4881-7. PubMed ID: 15611503
[TBL] [Abstract][Full Text] [Related]
2. Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma.
Fouladi M; Chintagumpala M; Ashley D; Kellie S; Gururangan S; Hassall T; Gronewold L; Stewart CF; Wallace D; Broniscer A; Hale GA; Kasow KA; Merchant TE; Morris B; Krasin M; Kun LE; Boyett JM; Gajjar A
J Clin Oncol; 2008 Aug; 26(22):3749-55. PubMed ID: 18669462
[TBL] [Abstract][Full Text] [Related]
3. Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1-3) Medulloblastoma--a safety/feasibility study.
Taylor RE; Howman AJ; Wheatley K; Brogden EE; Large B; Gibson MJ; Robson K; Mitra D; Saran F; Michalski A; Pizer BL
Radiother Oncol; 2014 Apr; 111(1):41-6. PubMed ID: 24630538
[TBL] [Abstract][Full Text] [Related]
4. Cumulative cisplatin dose is not associated with event-free or overall survival in children with newly diagnosed average-risk medulloblastoma treated with cisplatin based adjuvant chemotherapy: report from the Children's Oncology Group.
Nageswara Rao AA; Wallace DJ; Billups C; Boyett JM; Gajjar A; Packer RJ
Pediatr Blood Cancer; 2014 Jan; 61(1):102-6. PubMed ID: 23956184
[TBL] [Abstract][Full Text] [Related]
5. Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose Chemotherapy.
Lafay-Cousin L; Smith A; Chi SN; Wells E; Madden J; Margol A; Ramaswamy V; Finlay J; Taylor MD; Dhall G; Strother D; Kieran MW; Foreman NK; Packer RJ; Bouffet E
Pediatr Blood Cancer; 2016 Sep; 63(9):1527-34. PubMed ID: 27145464
[TBL] [Abstract][Full Text] [Related]
6. Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial.
Peyrl A; Chocholous M; Sabel M; Lassaletta A; Sterba J; Leblond P; Nysom K; Torsvik I; Chi SN; Perwein T; Jones N; Holm S; Nyman P; Mörse H; Öberg A; Weiler-Wichtl L; Leiss U; Haberler C; Schmook MT; Mayr L; Dieckmann K; Kool M; Gojo J; Azizi AA; André N; Kieran M; Slavc I
JAMA Oncol; 2023 Dec; 9(12):1688-1695. PubMed ID: 37883081
[TBL] [Abstract][Full Text] [Related]
7. Dose intensive melphalan and cyclophosphamide with autologous hematopoietic stem cells for recurrent medulloblastoma or germinoma.
Kadota RP; Mahoney DH; Doyle J; Duerst R; Friedman H; Holmes E; Kun L; Zhou T; Pollack IF
Pediatr Blood Cancer; 2008 Nov; 51(5):675-8. PubMed ID: 18623206
[TBL] [Abstract][Full Text] [Related]
8. Long-term Outcomes of Protocol-Based Treatment for Newly Diagnosed Medulloblastoma.
Ahn WK; Hahn SM; Yoon HI; Lee J; Park EK; Shim KW; Kim DS; Suh CO; Kim SH; Lyu CJ; Han JW
Cancer Res Treat; 2024 Apr; 56(2):652-664. PubMed ID: 38037318
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of amifostine and WR1065 in pediatric patients with medulloblastoma.
McKibbin T; Panetta JC; Fouladi M; Gajjar A; Bai F; Okcu MF; Stewart CF
Clin Cancer Res; 2010 Feb; 16(3):1049-57. PubMed ID: 20103669
[TBL] [Abstract][Full Text] [Related]
10. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
[TBL] [Abstract][Full Text] [Related]
11. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols.
Dhall G; Grodman H; Ji L; Sands S; Gardner S; Dunkel IJ; McCowage GB; Diez B; Allen JC; Gopalan A; Cornelius AS; Termuhlen A; Abromowitch M; Sposto R; Finlay JL
Pediatr Blood Cancer; 2008 Jun; 50(6):1169-75. PubMed ID: 18293379
[TBL] [Abstract][Full Text] [Related]
12. Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trial.
Dhall G; O'Neil SH; Ji L; Haley K; Whitaker AM; Nelson MD; Gilles F; Gardner SL; Allen JC; Cornelius AS; Pradhan K; Garvin JH; Olshefski RS; Hukin J; Comito M; Goldman S; Atlas MP; Walter AW; Sands S; Sposto R; Finlay JL
Neuro Oncol; 2020 Dec; 22(12):1862-1872. PubMed ID: 32304218
[TBL] [Abstract][Full Text] [Related]
13. Treatment of pediatric high-grade central nervous system tumors with high-dose methotrexate in combination with multiagent chemotherapy: A single-institution experience.
Bernstock JD; Alva E; Cohen JL; Lobbous M; Chagoya G; Elsayed GA; Orr BA; Rozzelle C; Rocque B; Blount J; Johnston JM; Li R; Fiveash JB; Dhall G; Reddy AT; Friedman GK
Pediatr Blood Cancer; 2020 Mar; 67(3):e28119. PubMed ID: 31850678
[TBL] [Abstract][Full Text] [Related]
14. PANCDR: precise medicine prediction using an adversarial network for cancer drug response.
Kim J; Park SH; Lee H
Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38487849
[TBL] [Abstract][Full Text] [Related]
15. Evolution of Systemic Therapy in Medulloblastoma Including Irradiation-Sparing Approaches.
Mushtaq N; Ul Ain R; Hamid SA; Bouffet E
Diagnostics (Basel); 2023 Dec; 13(24):. PubMed ID: 38132264
[TBL] [Abstract][Full Text] [Related]
16. Questions and answers in the management of children with medulloblastoma over the time. How did we get here? A systematic review.
Osuna-Marco MP; Martín-López LI; Tejera ÁM; López-Ibor B
Front Oncol; 2023; 13():1229853. PubMed ID: 37456257
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of a radiation sparing approach in medulloblastoma by subgroup in young children: an institutional review.
Ronsley R; Triscott J; Stanek J; Rassekh SR; Lum A; Cheng S; Goddard K; McConnell D; Strahlendorf C; Singhal A; Finlay JL; Yip S; Dunham C; Hukin J
Childs Nerv Syst; 2023 Aug; 39(8):2095-2104. PubMed ID: 37022464
[TBL] [Abstract][Full Text] [Related]
18. Effect of Autograft CD34
Knight TE; Ahn KW; Hebert KM; Atshan R; Wall DA; Chiengthong K; Rotz SJ; Fraint E; Rangarajan HG; Auletta JJ; Sharma A; Kitko CL; Hashem H; Williams KM; Wirk B; Dvorak CC; Myers KC; Pulsipher MA; Warwick AB; Lalefar NR; Schultz KR; Qayed M; Broglie L; Eapen M; Yanik GA
Transplant Cell Ther; 2023 Jun; 29(6):380.e1-380.e9. PubMed ID: 36990222
[TBL] [Abstract][Full Text] [Related]
19. High-Dose Chemotherapy in Children with Newly Diagnosed Medulloblastoma.
Lafay-Cousin L; Dufour C
Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159104
[TBL] [Abstract][Full Text] [Related]
20. Role of proliferative marker index and KBTBD4 mutation in the pathological diagnosis of pineal parenchymal tumors.
Uchida E; Sasaki A; Shirahata M; Suzuki T; Adachi JI; Mishima K; Yasuda M; Fujimaki T; Ichimura K; Nishikawa R
Brain Tumor Pathol; 2022 Jul; 39(3):130-138. PubMed ID: 35000018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
